Results 61 to 70 of about 33,357 (182)
Summary Parasomnias and sleep‐related movement disorders (SRMD) are major causes of sleep disorders and may be drug induced. The objective of this study was to conduct a systematic review of the literature to examine the association between drug use and the occurrence of parasomnias and SRMD.
Sylvain Dumont+5 more
wiley +1 more source
Impact of Cannabis Smoking on Multiple Sleep Latency Test Outcomes
ABSTRACT Our purpose was to evaluate how cannabis smoking influenced multiple sleep latency test (MSLT) outcomes. This was a retrospective study of all adults that had undergone a MSLT at St. Michael's Hospital (Toronto, Ontario, Canada) from 1 January 2008 until 31 December 2018.
Kosta Tzanis+3 more
wiley +1 more source
DGBI symptoms are common in obesity and have the potential to exacerbate negative health outcomes. In general, the prevalence of DGBI symptoms decreases after obesity treatment, but patients can also shift from one GI symptom profile to another. ABSTRACT Background & Aims Disorders of gut‐brain interaction (DGBI) in obesity could impair health outcomes.
Esther Colomier+11 more
wiley +1 more source
Time Course of Changes in Peripheral Blood Gene Expression During Medication Treatment for Major Depressive Disorder. [PDF]
Changes in gene expression (GE) during antidepressant treatment may increase understanding of the action of antidepressant medications and serve as biomarkers of efficacy.
Congdon, Eliza+6 more
core +1 more source
ABSTRACT Background/Aim The aim of this evidence map is to provide a systematic overview of evidence‐based guidelines for the management of obesity and to highlight discrepancies between recommendations for the pediatric and adult populations. Knowing about these discrepancies may be relevant during the transition from pediatrics to adult healthcare to
Jana Brauchmann+13 more
wiley +1 more source
Is a combination of varenicline and nicotine patch more effective in helping smokers quit than varenicline alone? A randomised controlled trial [PDF]
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work ...
A McEwen+26 more
core +2 more sources
Contemporary Concise Review 2024: Chronic Obstructive Pulmonary Disease
SUMMARY OF KEY POINTS Non‐smoking COPD is common in LMICs, especially in women. Biomass fuel and air pollution are major risk factors with distinct pathophysiology. The ‘eosinophilic’ endotype in COPD is biologically distinct from asthma. PRISm, FEV1/FVC Z‐scores, and quantitative CT improve early COPD detection.
Sarita Thawanaphong, Parameswaran Nair
wiley +1 more source
The Many Uses of Bupropion and Bupropion Sustained Release (SR) in Adults [PDF]
Sir: Bupropion is an antidepressant originally approved by the U.S. Food and Drug Administration (FDA) in 1989 for the treatment of depression.1 Its unique mechanism of action among antidepressants is thought to be due to reuptake of dopamine and norepinephrine.2 In 1997, the FDA approved bupropion sustained release (SR) for the treatment of smoking ...
openaire +3 more sources
Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised study [PDF]
Aim To investigate the safety and efficacy of bupropion sustained release (bupropion SR) in promoting abstinence from smoking in subjects with cardiovascular disease (CVD).
Astbury, C.+10 more
core
ABSTRACT Electronic cigarette (EC) use, especially among younger members of society, has grown to concerning levels in many countries, including Australia and New Zealand. Uptake in the general population, driven by technological and pharmacological innovations, and accelerated by aggressive tobacco/vaping industry marketing, has outpaced medical ...
Henry Marshall+13 more
wiley +1 more source